Publications by authors named "Massimo Triggiani"

Claim this Profile
T
The Impact of COVID-19 on Patients With Bradykinin-Mediated Angioedema in the ITACA Cohort.
Riccardo Senter, Andrea Zanichelli, Agolini Stefano, Francesco Arcoleo, Donatella Bignardi, Massimo Triggiani

Clin Exp Allergy· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upadacitinib is efficacious in reducing the alexithymic trait in adult patients with moderate-to-severe atopic dermatitis: a prospective multicenter real-life study.
Eustachio Nettis, Mattia Cristallo, Carmen S Fiorella, Angela Giuliani, Vincenzo Patella, Massimo Triggiani

Ital J Dermatol Venerol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of KIT D816V in anaphylaxis or systemic mast cell activation.
Karin Hartmann, Ivan Alvarez-Twose, Jonathan A Bernstein, Cem Akin, Bethan Myers, Massimo Triggiani

J Allergy Clin Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes and Provider Perceptions of Systemic Mastocytosis: Results From the PRISM Study.
Massimo Triggiani, Jessica Hobart, Iván Alvarez-Twose, Cristina Bulai Livideanu, Franziska Ruëff

Clin Exp Allergy· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The LUNET Project: Developing the Italian Systemic Erythematous Lupus Network.
Ilaria Mormile, Luisa Brussino, Giorgio Walter Canonica, Francesca Cortini, Maria Teresa Costantino, Massimo Triggiani

J Clin Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Profiling of Cytokines and Growth Factors: Pathogenic Roles and Clinical Applications in Autoimmune Diseases.
Anna Donniacuo, Arianna Mauro, Chiara Cardamone, Anna Basile, Paola Manzo, Massimo Triggiani

Int J Mol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of potential drug-drug interactions in patients with hereditary angioedema from the ITACA cohort: simulations from a real-life dataset considering danazol versus berotralstat.
Andrea Zanichelli, Dario Cattaneo, Antonio Gidaro, Riccardo Senter, Francesco Arcoleo, Massimo Triggiani

Front Pharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of expression of CD2, CD25, and/or CD30 in/on mast cells in systemic mastocytosis: a registry study of the European Competence Network on Mastocytosis.
Axel Rüfer, Henning Nilius, Olivier Hermine, Marek Niedoszytko, Joanne N G Oude Elberink, Massimo Triggiani

Leukemia· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab.
Danilo Di Bona, Massimo Bilancia, Claudia Crimi, Michelina Daddato, Alida Benfante, Massimo Triggiani

Clin Exp Allergy· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study.
Claudia Crimi, Santi Nolasco, Alberto Noto, Angelantonio Maglio, Vitaliano Nicola Quaranta, Massimo Triggiani

J Allergy Clin Immunol Pract· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM.
Peter Valent, Karin Hartmann, Gregor Hoermann, Andreas Reiter, Iván Alvarez-Twose, Massimo Triggiani

J Allergy Clin Immunol Pract· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asthma remission one, none and one-hundred thousand: the relevance of the patient's view.
Matteo Bonini, Simona Barbaglia, Gianna Camiciottoli, Stefano Del Giacco, Fabiano Di Marco, Massimo Triggiani

J Asthma· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry.
Marek Niedoszytko, Aleksandra Gorska, Knut Brockow, Patrizia Bonadonna, Magdalena Lange, Massimo Triggiani

Allergy· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus.
Avner Reshef, Thomas Buttgereit, Stephen D Betschel, Teresa Caballero, Henriette Farkas, Massimo Triggiani

J Allergy Clin Immunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC).
Marco Caminati, Luisa Brussino, Matilde Carlucci, Palma Carlucci, Lucia Federica Carpagnano, Massimo Triggiani

Cells· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of death, thrombotic and hemorrhagic events in anticoagulated patients with atrial fibrillation and systemic autoimmune diseases: an analysis from a global federated dataset.
Tommaso Bucci, Chiara Cardamone, Massimo Triggiani, Paul R J Ames, Gregory Y H Lip

Clin Res Cardiol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM.
Johannes Lübke, Alicia Schmid, Deborah Christen, Hanneke N G Oude Elberink, Lambert F R Span, Massimo Triggiani

Blood Adv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission.
Giovanna Elisiana Carpagnano, Andrea Portacci, Santi Nolasco, Aikaterini Detoraki, Alessandro Vatrella, Massimo Triggiani

Front Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymic stromal lymphopoietin (TSLP) is a substrate for tryptase in patients with mastocytosis.
Simone Marcella, Angelica Petraroli, Luisa Canè, Anne Lise Ferrara, Remo Poto, Massimo Triggiani

Eur J Intern Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-grade endotoxemia and risk of recurrent thrombosis in primary antiphospholipid syndrome. The multicenter ATHERO-APS study.
Tommaso Bucci, Paul R J Ames, Vittoria Cammisotto, Chiara Cardamone, Antonio Ciampa, Massimo Triggiani

Thromb Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT.
Peter Valent, Gregor Hoermann, Patrizia Bonadonna, Karin Hartmann, Wolfgang R Sperr, Massimo Triggiani

J Allergy Clin Immunol Pract· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.
Andrea Portacci, Raffaele Campisi, Enrico Buonamico, Santi Nolasco, Corrado Pelaia, Massimo Triggiani

ERJ Open Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study.
Santi Nolasco, Andrea Portacci, Raffaele Campisi, Enrico Buonamico, Corrado Pelaia, Massimo Triggiani

Front Immunol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience.
Giulia Scioscia, Pasquale Tondo, Santi Nolasco, Corrado Pelaia, Giovanna Elisiana Carpagnano, Massimo Triggiani

J Clin Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avapritinib versus Placebo in Indolent Systemic Mastocytosis.
Jason Gotlib, Mariana Castells, Hanneke Oude Elberink, Frank Siebenhaar, Karin Hartmann, Massimo Triggiani

NEJM Evid· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis